An observational study in Shoulder Injuries, sponsored by Al-Azhar University. Not yet recruiting. Open to participants aged 15 Years to 55 Years. Per ClinicalTrials.gov, last updated 2024-01-05.
Sponsored by Al-Azhar University · Observational
to evaluate the clinical and radiological Outcome of Distal Clavicle Auto graft in patient with recurrent Shoulder dislocation
The glenohumeral joint is the most commonly dislocated joint of the human body,The stability of GH joint relies on a complex network of static and dynamic structures,The anterior labrum plays a key role in antero posterior stability as it deepens the glenoid cavity up to 50% There option for glenoid reconstruction including: Distal Clavicle Auto graft (DCA), proven is a good option to coracoid transfers
118 studies on the registry are indexed under Shoulder Injuries; 32 are open to participants now.
This study's planned enrollment of 30 is below the median of 60 across 45 observational studies indexed under Shoulder Injuries.
Browse Shoulder Injuries studies →Al-Azhar University is the lead sponsor of 531 studies on the registry; 172 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Range of motion "ROM" (Forward flexion, external rotation, internal rotation) Preoperative and postoperative ROM . Rowe score, Visual analogue score (VAS). Secondary outcomes postoperative complications will be evaluated.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
.On-track Hill-Sachs lesion. .Multi directional instability.
Row score
Rang of motion
Time frame: At 2 months, 6 months post operative
No study locations are listed for this record.
Start is estimated for Jan 2024; primary completion for Jan 2025, 12 months later.
Of 24 observational studies under Shoulder Injuries, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 45. This study's planned 12 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.